Singapore's rapidly ageing population faces a silent epidemic: over one in three seniors aged 60 and above are living with at least one undiagnosed age-related eye disease, according to groundbreaking findings from the PIONEER study led by the Singapore Eye Research Institute (SERI). This cross-sectional cohort research, involving nearly 2,000 community-dwelling Chinese, Malay, and Indian adults, underscores the persistent gap in eye health awareness and screening, even in a nation renowned for its advanced healthcare system. With visual impairment affecting 43 per cent of participants, the implications extend far beyond vision loss, touching on quality of life, cognitive health, and economic productivity.

The PIONEER study—short for PopulatION HEalth and Eye Disease PRofilE in Elderly Singaporeans—represents a comprehensive effort to map sensory and physical declines in seniors. Conducted from December 2017 to November 2022, it highlights how conditions like cataracts, glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR) often go undetected, particularly among younger seniors and non-Chinese ethnic groups. As Singapore's population ages—with projections showing one in four residents over 65 by 2030—these revelations call for urgent, targeted interventions rooted in university-led research excellence.

Understanding the PIONEER Study: Methodology and Scope

The PIONEER study, spearheaded by SERI—a research institute under the Singapore National Eye Centre (SNEC) and closely affiliated with Duke-NUS Medical School and the National University of Singapore (NUS)—enrolled 2,636 participants aged 60 to 102 from diverse ethnic backgrounds. A subset of 1,878 underwent detailed ophthalmic examinations by study ophthalmologists, using standardized protocols including logMAR visual acuity charts and retinal imaging. Undiagnosed cases were defined as those without prior physician confirmation or interventions like surgery or medication.

This rigorous, population-based approach builds on earlier Singapore Epidemiology of Eye Diseases (SEED) studies from over a decade ago, confirming that high undiagnosed rates persist. Weighted prevalence calculations accounted for ethnic representation, revealing 35.8 per cent of seniors with at least one undiagnosed eye disease—87.6 per cent with one condition, 11.7 per cent with two, and 0.7 per cent with three. Such depth in data collection exemplifies how Singapore's universities drive evidence-based public health advancements.

Breaking Down the Eye Diseases: Cataracts, Glaucoma, AMD, and DR

Cataracts, the clouding of the eye's lens leading to blurred vision, topped the list with 40.8 per cent undiagnosed among affected individuals. Often dismissed as normal ageing ('lao hua yan' in local parlance), untreated cases contribute significantly to reversible visual impairment.

• Glaucoma (48.1 per cent undiagnosed): The 'silent thief of sight,' damaging the optic nerve without early symptoms; prevalence higher in Malays.
• Age-related Macular Degeneration (AMD, 89.8 per cent undiagnosed): Affects central vision; early detection via anti-VEGF injections can preserve sight.
• Diabetic Retinopathy (DR, 89.8 per cent undiagnosed): Complication of diabetes harming retinal blood vessels; critical given Singapore's high diabetes rates.

These statistics mirror global trends but highlight Asia-specific burdens, with SERI researchers noting ethnic variations—Malays and Indians facing 1.71 and 1.43 times higher odds than Chinese, respectively.

Ethnic Disparities and Key Risk Factors

Ethnicity plays a pivotal role: Malays showed the highest undiagnosed rates for cataracts and glaucoma, while Indians followed closely. Chinese seniors, conversely, exhibited higher pre-sarcopenia. Risk factors include younger age within the senior bracket (odds ratio 1.08 per year decrease), multifocal glasses use (OR 1.75), and lower socioeconomic access to screening.

Overlapping comorbidities exacerbate risks: 65 per cent overweight/obese, 88 per cent poor muscle health. Professor Ecosse Lamoureux, SERI's principal investigator, emphasizes, “As you age, multiple systems age simultaneously—sensory, muscular, brain—necessitating holistic approaches.” For more on careers advancing such multi-ethnic research, explore higher-ed-jobs in ophthalmology at Duke-NUS.

Beyond Eyes: Interconnected Sensory and Physical Declines

PIONEER reveals a web of impairments: 70 per cent hearing impairment (20 per cent significant, <1 per cent using aids), 27 per cent smell loss, and 20 per cent triple sensory deprivation—tripling daily functioning issues and quadrupling healthcare costs. Sarcopenia affects 40 per cent, linking vision loss to falls, cognitive decline, and frailty.

Dr Preeti Gupta, NUS clinician-scientist, notes surprise at hearing aid underuse: “Less than 1 per cent despite widespread need.” This multisystem view, pioneered by SERI-NUS collaborations, informs integrated care models.

Profound Impacts on Quality of Life and Daily Functioning

Undiagnosed cases slash health-related quality of life by 1.97-4.57 per cent and double visual impairment odds (OR 2.46). Seniors struggle with reading, mobility, and social engagement, accelerating isolation and dementia risk. Triple impairment amplifies this threefold, per validated questionnaires like NEI VFQ-25.

Real-world cases: A Malay senior with undetected glaucoma risks irreversible blindness; an Indian cataract patient faces preventable falls. University research here translates to actionable insights, training future ophthalmologists via higher-ed-career-advice.

The Economic Toll: Higher Costs from Underdiagnosis

Undiagnosed seniors incur 1.73-fold higher expenditures, straining Singapore's healthcare system amid ageing. Early screening averts costly late interventions—cataract surgery at S$3,000-5,000 vs. blindness management.

Nationwide, Vision 2030 targets halving blindness by subsidizing screenings. SERI's data bolsters cost-effectiveness models for policymakers.SNEC VisionSave exemplifies this, delivering mobile clinics since 2017.

Singapore's Response: Screening Programs and Vision 2030

The Ministry of Health champions Project Silver Screen for vision/hearing/oral checks, while SNEC's VisionSave buses screen underserved seniors. Free polyclinic screenings and CHAS subsidies target at-risk groups. SERI-Duke-NUS drives innovation, like AI retinal screening pilots.

Recommendations: Tailor campaigns for Malays/Indians, promote annual checks for multifocal wearers. For aspiring researchers, university-jobs at NUS Ophthalmology abound.

Expert Insights and University-Led Innovations

Prof Lamoureux advocates holistic care: “Interconnected declines demand comprehensive strategies for healthy longevity.” Dr Gupta highlights muscle-sensory links: “40 per cent sarcopenia surprises; reversible with intervention.”

SERI's 17 PIONEER papers (2017-2025) fuel global citations. Duke-NUS/NUS train clinician-scientists, positioning Singapore as ophthalmic research hub.Read the JAMA paper.

Future Outlook: Follow-Up Research and Actionable Steps

PIONEER follow-ups to 2027 will track progression to frailty/dementia. AI integration promises scalable screening; SERI pioneers this.

Photo by Alexandre Lecocq on Unsplash

• Actionable advice: Annual eye exams, manage diabetes/hypertension, healthy weight/muscle training.
• For families: Encourage screenings via HealthHub app.

Careers in Ophthalmic Research: Opportunities at Singapore Universities

This study spotlights demand for eye health experts. Duke-NUS/SERI/NUS offer PhDs, postdocs in epidemiology, AI diagnostics. Check higher-ed-jobs/faculty, higher-ed-jobs/postdoc, rate-my-professor for insights. Drive change—apply today for higher-ed-jobs, higher-ed-career-advice, university-jobs.